| A Phase II Trial of Afatinib(BIBW 2992) in Third-line Treatment for Patients With Stage IIIB/IV Adenocarcinoma of the Lung Harbouring Wild-type Epidermal Growth Factor Receptor[EGFR] (NCT01003899) | Boehringer Ingelheim | 2009-10-01 |
| A Phase I Study of iPS Cell Generation From Patients With COPD (NCT01860898) | Mayo Clinic | 2009-09-01 |
| Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy (NCT01022671) | Chong Kun Dang Pharmaceutical | 2009-09-01 |
| An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene (NCT00932893) | Pfizer | 2009-09-01 |
| Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer (NCT00921310) | Washington University School of Medicine | 2009-09-01 |
| BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation (NCT00949650) | Boehringer Ingelheim | 2009-08-14 |
| Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer (NCT00954278) | University of Wisconsin, Madison | 2009-07-28 |
| Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer (NCT00946673) | Stanford University | 2009-06-01 |
| Computed Tomography (CT) Perfusion Imaging of Lung Cancer (NCT00905801) | University of Pittsburgh | 2009-06-01 |
| Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients (NCT01192230) | Fudan University | 2009-06-01 |
| Effect of Astragalus-based Formula: Qingshu-Yiqi-Tang on Modulating Immune Alterations in Lung Cancer Patients (NCT01802021) | Chang Gung Memorial Hospital | 2009-05-01 |
| A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... (NCT00923481) | National Cancer Institute (NCI) | 2009-04-01 |
| TAilored Post-Surgical Therapy in Early Stage NSCLC (NCT00775385) | Intergroupe Francophone de Cancerologie Thoracique | 2009-04-01 |
| 2nd Line Erlotinib Treatment With (Out) Chemotherapy of Advanced Non Small Cell Lung Cancer (NSCLC) (NCT00835471) | Dutch Society of Physicians for Pulmonology and Tuberculosis | 2009-03-01 |
| Trial of BI 6727 (Volasertib) Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLC (NCT00824408) | Boehringer Ingelheim | 2009-03-01 |
| Temsirolimus and Radiation for Non-Small Cell Lung Cancer (NCT00796796) | Washington University School of Medicine | 2009-03-01 |
| Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin for Non-Small Cell Lung Cancer With KRAS or EGFR Activation (NCT00861627) | Oncolytics Biotech | 2009-03-01 |
| Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung Cancer (NCT01956331) | Groupe Francais De Pneumo-Cancerologie | 2009-03-01 |
| BIBF 1120 + Docetaxel (Japan) in Patients With Advanced Non-small-cell Lung Cancer, Phase I (NCT00876460) | Boehringer Ingelheim | 2009-03-01 |
| Phase I Imaging Study Evaluating Dalotuzumab (MK0646) in Combination With Erlotinib for Patients With Non-Small Cell Lung Cancer (MK-0646-008) (NCT00729742) | Merck Sharp & Dohme LLC | 2009-02-01 |
| Modafinil for the Treatment of Fatigue in Lung Cancer V9.0 (NCT00829322) | University of Oxford | 2009-02-01 |
| Effect of Qigong Therapy in Patients With Advanced Lung and Gastrointestinal Cancer Undergoing Chemotherapy (NCT01374100) | McGill University | 2009-02-01 |
| Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC) (NCT00824746) | Chonnam National University Hospital | 2009-01-01 |
| An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC) (NCT00826878) | AVEO Pharmaceuticals, Inc. | 2009-01-01 |
| Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer (NCT00768755) | Pfizer | 2009-01-01 |
| LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer (NCT00805194) | Boehringer Ingelheim | 2008-12-03 |
| Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC (NCT00806819) | Boehringer Ingelheim | 2008-12-01 |
| BIBW2992 (Afatinib) in Advanced (EGFR-FISH +) NSCLC (Non Small Cell Lung Cancer) Patients (NCT00796549) | Boehringer Ingelheim | 2008-12-01 |
| Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT (NCT01261585) | Centre Henri Becquerel | 2008-12-01 |
| Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer (NCT00798720) | University of Wisconsin, Madison | 2008-12-01 |
| Role of a Silicone Prosthesis to Prevent Airway Obstruction Recurrence in Lung Cancers (NCT01064050) | Centre Hospitalier Universitaire de Saint Etienne | 2008-11-01 |
| Adjuvant Pazopanib in Stage I NSCLC (NCT00775307) | Intergroupe Francophone de Cancerologie Thoracique | 2008-11-01 |
| Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating (NCT00690963) | AHS Cancer Control Alberta | 2008-09-01 |
| Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer (NCT00791336) | University of Iowa | 2008-08-01 |
| Natural Killer Cells and Bortezomib to Treat Cancer (NCT00720785) | National Heart, Lung, and Blood Institute (NHLBI) | 2008-08-01 |
| SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716) (NCT00732810) | Merck Sharp & Dohme LLC | 2008-07-01 |
| DNA Chip Based Prognosis of Lung Cancer (NCT00973427) | Medical Prognosis Institute A/S | 2008-06-01 |
| Single-arm Trial of BIBW 2992 (Afatinib) in Demographically and Genotypically Selected NSCLC Patients (NCT00730925) | Boehringer Ingelheim | 2008-06-01 |
| Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer (NCT00673049) | Pfizer | 2008-05-01 |
| PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib (NCT00548093) | Pfizer | 2008-04-29 |
| Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology (NCT00596830) | Pfizer | 2008-04-01 |
| LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (NCT00711594) | Boehringer Ingelheim | 2008-04-01 |
| BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1) (NCT00656136) | Boehringer Ingelheim | 2008-04-01 |
| A Study Evaluating Dalotuzumab (MK-0646) in Combination With Erlotinib for Participants With Non-Small Cell Lung Cancer (MK-0646-007) (NCT00654420) | Merck Sharp & Dohme LLC | 2008-03-19 |
| Study of Maintenance Temozolomide Versus Observation in Stable or Responding Stage III/IV Non-Small Cell Lung Cancer Patients (Study P05146) (NCT00632203) | Merck Sharp & Dohme LLC | 2008-03-04 |
| N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy (NCT00637624) | Rijnstate Hospital | 2008-03-01 |
| Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer (NCT00622193) | Helsinn Therapeutics (U.S.), Inc | 2008-03-01 |
| Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer (NCT00923273) | National Cancer Institute (NCI) | 2008-02-29 |
| A Study of XL184 (Cabozantinib) With or Without Erlotinib in Subjects With Non-Small Cell Lung Cancer (NSCLC) (NCT00596648) | Exelixis | 2008-02-12 |
| Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer (NCT00553254) | Pfizer | 2008-02-05 |
| Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma (NCT00625352) | Ulsan University Hospital | 2008-02-01 |
| Study to Evaluate Erlotinib With or Without SNDX-275 (Entinostat) in the Treatment of Patients With Advanced NSCLC (NCT00602030) | Syndax Pharmaceuticals | 2008-01-08 |
| Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer (NCT00603538) | Pfizer | 2008-01-01 |
| Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment (NCT00585845) | Anza Therapeutics, Inc. | 2007-12-01 |
| Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer (NCT00545948) | Duke University | 2007-12-01 |
| Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NCT00522938) | Chroma Therapeutics | 2007-12-01 |
| Study Of CP-751,871 In Combination With Cisplatin And Gemcitabine In Chemotherapy-Naïve Patients With Advanced Non-Small Cell Lung Cancer (NCT00560573) | Pfizer | 2007-11-01 |
| Phase II Study Evaluating The Safety And Response To Neoadjuvant Dasatinib In Early Stage Non-Small Cell Lung Cancer (NCT00564876) | Duke University | 2007-11-01 |
| Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabine/Cisplatin Plus Bevacizumab (NCT00536640) | Aktion Bronchialkarzinom e.V. | 2007-11-01 |
| Safety and Efficacy Study of Betamarc to Treat Loss of Weight and Appetite in Non-Small Cell Lung Cancer (NCT00535015) | Anaborex | 2007-10-01 |
| Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) Patients (NCT00905983) | Hospital Arnau de Vilanova | 2007-10-01 |
| Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC) (NCT00568841) | Lung Cancer Group Cologne | 2007-10-01 |
| Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT00536107) | AstraZeneca | 2007-10-01 |
| A Phase 1-2 XIAP Antisense AEG35156 With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (NCT00558922) | Aegera Therapeutics | 2007-09-01 |
| A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC) (NCT00558636) | Bayer | 2007-09-01 |
| NSCLC Relapse Therapy After Surgery and Peri-operative Chemotherapy (NCT00535275) | Intergroupe Francophone de Cancerologie Thoracique | 2007-09-01 |
| Study of Salirasib to Treat Non-Small Cell Lung Cancer (NCT00531401) | Concordia Pharmaceuticals, Inc | 2007-09-01 |
| Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC) (NCT00600587) | Guangdong Provincial People's Hospital | 2007-09-01 |
| DNA Repair Genes and Outcomes in Patients With Stage III NSCLC (NCT00797238) | National Taiwan University Hospital | 2007-09-01 |
| Sorafenib in Resected Non-small Cell Lung Carcinoma (NCT00532025) | Johannes Gutenberg University Mainz | 2007-09-01 |
| Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer Patients (NCT00539331) | AstraZeneca | 2007-09-01 |
| LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations (NCT00525148) | Boehringer Ingelheim | 2007-08-01 |
| Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer (NCT00553800) | Fox Chase Cancer Center | 2007-07-05 |
| A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone (NCT00457392) | Pfizer | 2007-07-01 |
| Phase I Study of Iressa and CRT/IMRT in Chinese Patients With IIIB/IV NSCLC After Failure of Platinum-Based Chemotherapy (NCT00497250) | Fudan University | 2007-07-01 |
| Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib (NCT00522145) | Kadmon Corporation, LLC | 2007-05-01 |
| A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel. (NCT00386555) | Arog Pharmaceuticals, Inc. | 2007-05-01 |
| Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus Sorafenib (NCT00473486) | University Hospital Muenster | 2007-05-01 |
| Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer (NCT00400803) | Masonic Cancer Center, University of Minnesota | 2007-03-01 |
| Efficacy and Safety of Cetuximab in Combination With Cisplatin Gemcitabine as First-Line Therapy in Advanced NSCLC (NCT00561054) | Grupo Portugues de Estudo do Cancro do Pulmao | 2007-03-01 |
| A Phase III Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patients With Stage IIIb With Effusion and Stage IV Non-Small Cell Lung Cancer (NSCLC) (NCT00449033) | Bayer | 2007-02-01 |
| Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED) (NCT00423150) | Merck Sharp & Dohme LLC | 2007-01-26 |
| Vaccine Maintenance Treatment for Non-Small Cell Lung Cancer (NCT00420732) | NewLink Genetics Corporation | 2007-01-01 |
| Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC) (NCT00406302) | Wolfgang Hilbe | 2007-01-01 |
| VATS Lobectomy for Clinical Stage IB or II Lung Cancer (NCT00425022) | National Cancer Center, Korea | 2007-01-01 |
| Assessment of Surgical sTaging vs Endoscopic Ultrasound in Lung Cancer: a Randomized Clinical Trial (ASTER Study) (NCT00432640) | University Hospital, Ghent | 2007-01-01 |
| LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy (NCT00328588) | Astellas Pharma Inc | 2006-12-01 |
| GV 1001 Immunotherapy in Patients With Non-small Cell Lung Cancer (NSCLC) (NCT00509457) | Oslo University Hospital | 2006-11-01 |
| Pilot Study of Preoperative Tarceva (Erlotinib) for Stages I/II Non-Small Cell Lung Cancer (NCT00385996) | Weill Medical College of Cornell University | 2006-10-01 |
| Dose Escalation Study of BI 2536 With Pemetrexed in Previously Treated Patients With Non-small-cell Lung Cancer (NCT02211833) | Boehringer Ingelheim | 2006-10-01 |
| A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies (NCT00441337) | Bristol-Myers Squibb | 2006-08-01 |
| Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer (NCT00321815) | Pfizer | 2006-08-01 |
| Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer (NCT00376623) | Boehringer Ingelheim | 2006-07-25 |
| Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC) (NCT01069328) | Bayer | 2006-07-01 |
| Erlotinib and Standard Platinum-Based Chemotherapy for Newly Diagnosed, Advanced Non-Small Cell Carcinoma of the Lung (NCT00391586) | New Mexico Cancer Research Alliance | 2006-07-01 |
| Prevention of Radiation Pneumonitis After Three-dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-small-cell Lung Cancer (NCT00349102) | Centre Leon Berard | 2006-07-01 |
| A Study In Patients With Non-Small Cell Lung Cancer Testing If Erlotinib Plus SU011248 (Sunitinib) Is Better Than Erlotinib Alone (NCT00265317) | Pfizer | 2006-06-01 |
| A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006) (NCT00290550) | Merck Sharp & Dohme LLC | 2006-06-01 |
| Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC) (NCT00312975) | AstraZeneca | 2006-05-01 |
| Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer (NCT00329472) | Samsung Medical Center | 2006-04-01 |